AI blind-sweep obstetric ultrasound by non-specialists in rural DRC
Official title: Diagnostic Accuracy and Implementation Feasibility of AI-Assisted Blind Ultrasound Sweep (SPAQ E-con AI) for Antenatal Screening by Non-Specialist Health Workers in Rural Democratic Republic of the Congo
Run by SOIK Corporation Sarl · NCT07677670 · Data updated 2026-11-12
Researchers test an AI-assisted blind-sweep ultrasound to screen pregnant women in rural Democratic Republic of Congo, using non-specialist health workers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 3000 (estimated) |
| Sponsor | SOIK Corporation Sarl Industry-sponsored |
| Locations | 1 site (Kenge, Kwango) |
| Status | Recruiting |
| Started | June 19, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | June 13, 2027 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT07677670 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 years or older presenting for routine antenatal care at participating facilities in Kenge, Kwango province, including those reachable via village outreach.
✕Probably not a fit
Women with planned relocation outside Kwango or unable to provide consent may not benefit from the study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the diagnostic accuracy and feasibility of a AI-assisted blind-sweep obstetric ultrasound (SPAQ E-con AI) operated by trained non-specialist health workers during antenatal screening in rural DRC. It follows a Hybrid Type 1 design to assess both effectiveness and implementation, with model updates planned after interim analyses. Primary outcomes focus on gestational age estimation accuracy and AI confidence calibration, using manual ultrasound measurements as the reference standard. Enrollment targets include about 1,380 participants across two batches, with a ceiling of 3,000 and potential early stop if predefined criteria are met. The study is conducted at up to six facilities in the Kenge health zone, Kwango province, plus village outreach sites, and includes sub-cohorts for early and late gestational ages.
Why it matters
Potential benefit: If successful, this approach could enable accurate antenatal screening in resource-limited settings using non-specialist workers and AI-augmented imaging.
How similar studies have gone: Prior studies in AI-guided point-of-care ultrasound have shown promise in various settings, but this specific blind-sweep approach with non-specialist operators in rural Africa is relatively novel and under evaluation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women aged 18 years or older * Identified at a participating facility routine ANC visit or RECO village outreach within the Kenge health zone catchment * Written informed consent obtained Exclusion Criteria: * Emergency presentation * Duplicate re-registration of an already-enrolled woman * Lacking capacity to consent * Planned relocation outside Kwango province during the study period * Refusal of consent
Where it's running
-
Centre de Sante CBCO
Kenge, Kwango, Democratic Republic of the Congo Recruiting
Study contacts
- Principal investigator: Kuniyuki Furuta — SOIK Corporation
- Study coordinator: Kuniyuki Furuta
- Email: furuta@soik.co.jp
- Phone: +818099740409
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using infrared cameras to help detect juvenile arthritis in kids
This study tests whether infrared thermography can help identify joint inflammation in children with juvenile idiopathic arthritis compared with standard tests.
-
Automated Echocardiography Measurements Using Deep-Learning Software
This study tests whether US2.AI can automatically measure heart structure and function from standard echocardiograms as accurately as expert clinicians in adults.
-
Timing of AI Help in Chest X-Rays: Does When AI Becomes Visible Change How Clinicians Read Images?
Doctors test chest X-ray interpretation with AI information shown either before or after they start reviewing the image to see how timing affects their search patterns and decisions.
-
Nutrition and breastfeeding: following moms and babies in Arkansas
This study will test how mothers’ diets and social factors like food access relate to breastfeeding outcomes and baby health, following participants from late pregnancy through the first year after birth.
-
Routine STI screening during pregnancy to improve birth outcomes
This study tests whether adding screening and treatment for chlamydia and gonorrhoea to standard antenatal care can reduce preterm birth and other problems for pregnant women in Botswana.
-
Deep-learning tool to distinguish T1–T2 from T3 renal cell carcinoma on contrast-enhanced CT.
This project will see if a computer model can tell whether kidney cancer is early (T1–T2) or locally advanced (T3) using contrast-enhanced CT scans before surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.